See our newest publication: 1) Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γELISpot: A Multicenter, Prospective Observational Study.
Barrios EA, Mazer MB, McGonagill P, Bergmann CB, Goodman MD, Gould R, Rao M, Polcz V, Davis R, Del Toro D, Dirain M, Dram A, Hale L, Heidarian M, Kucaba TA, Lanz JP, McCray A, Meszaros S, Miles S, Nelson C, Rocha I, Silva EE, Ungaro R, Walton A, Xu J, Zeumer-Spataro L, Drewry A, Liang M, Bible LE, Loftus T, Turnbull I, Efron PA, Remy KE, Brakenridge S, Badovinac VP, Griffith TS, Moldawer LL, Hotchkiss RS, Caldwell CC. medRxiv. 2023 Sep 24:2023.09.13.23295360. doi: 10.1101/2023.09.13.23295360. Preprint. PMID: 37745385 (In Press, Journal of Clinical Investigation)
2) The Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS) Ten Years Later.
Efron PA, Brakenridge SC, Mohr AM, Barrios EL, Polcz VE, Anton S, Ozrazgat-Baslanti T, Bihorac A, Guirgis F, Loftus TJ, Rosenthal M, Leeuwenburgh C, Mankowski R, Moldawer LL, Moore FA. J Trauma Acute Care Surg. 2023 Aug 8. doi: 10.1097/TA.0000000000004087. Epub ahead of print. PMID: 37561664.
news in sepsis
Patient Safety and Quality Week Activities
The SCIRC is looking forward to participating in the 2024 Patient Safety and Quality Week! Please join us and the Department of…
Dr. Alicia Mohr Shock Society Executive Council…
Congratulations to Dr. Alicia Mohr as the newly elected Shock Society Clinical Councilor…
Advancing Research Capabilities: A Look into the…
In the realm of medical research, the pursuit of knowledge is often intricately linked with the capabilities of the laboratory space available. The…